Donaueschingen (pta010/17.05.2022/08:45) - Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by 13% and EBIT by approx. 19% in the first three months of 2022. As a result, the continually positive development of sales and earnings of the last years could be continued.
Sales improved from KEUR 43,940 to KEUR 49,498 (+12.6%) in the first three months 2022. The international share of total business volume was 48.1% ((3M-2021) 47.2%) and amounted to KEUR 23,785 compared to KEUR 20,728 (3M-2021).
The EBITDA increased by 12.0% to KEUR 10,175 ((3M-2021) KEUR 9,086). The EBITA increased by 17.3% from KEUR 6,105 (3M-2021) to KEUR 7,161 and the consolidated earnings before interest and taxes (EBIT) rose very sharply by 18.5% to KEUR 5,985 ((3M-2021) KEUR 5,049). The consolidated surplus rose by 15.0% to KEUR 4,393 ((3M-2021) KEUR 3,820).
As of 31/03/2022, the company had cash resources at its disposal in the amount of KEUR 46,279 (31/12/2021: KEUR 26,172). Nexus AG had equity capital amounting to KEUR 144,545 as of 31/03/2022 (31/12/2021: KEUR 142,403). Consequently, the equity capital rate is 53.6% (31/12/2021: 57.6%).
The Managing Board(end)
|contact person:||Hannes Wehinger|
|phone:||+49 771 22960-260|
|stock exchanges:||regulated market in Frankfurt, Hamburg; free market in Dusseldorf, free market in Munich, free market in Stuttgart; open market in Berlin|